Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    WEBINAR TRAINING ON POST MARKET SURVEILLANCE OF ME 2017 - Spotlight on Post Market Surveillance - By AtoZ Compliance

    View: 123

    Website https://www.atozcompliance.com/trainings-webinar/life-sciences/medical-devices/post-market-surveilla | Want to Edit it Edit Freely

    Category Quality Engineers,Medical Device,Compliance Specialists,Clinical Affairs Personnel,Life science

    Deadline: February 23, 2017 | Date: February 23, 2017

    Venue/Country: Online, U.S.A

    Updated: 2017-02-20 14:57:33 (GMT+9)

    Call For Papers - CFP

    Key Take Away :

    This webinar will discuss the essentials of Post Market Surveillance, how you can develop your capabilities and how PMS can provide you with important information to improve your device, better service your customers, and reduce the risk of adverse events.

    Overview :

    Post Market Surveillance (PMS) is the practice and system of monitoring the safety awareness training of a medical device after it has been released on the market.

    It relies on several foundations including unique device identifiers (UDI), electronic health records and medical device reporting, device registries, and advance methods for evidence generation, data analysis and vigilance awareness training. It is a system that continues to develop and improve.

    Why Should You Attend :

    Post Market Surveillance is an essential part of the FDA’s mandate to protect the public health. This Post Market Surveillance and Vigilance Webinar will establish why it is something that every medical device company needs to understand to ensure product safety and effectiveness and customer satisfaction.

    Areas Covered In This Webinar :

    Overview and Definitions

    FDA Expectations, Regulations

    Lessons Learned and Enforcement Case Studies

    Medical Device Reporting

    Learning Objectives :

    Investigating a complaint or MDR

    FAERS – FDA Adverse Event Reporting System

    Common Mistakes and how to avoid them

    Best Practices

    Preparing for an FDA or NB Inspection

    Who Will Benefit :

    Complaint Specialists and Managers

    Individuals participating in Failure Investigations

    Individuals analyzing Returned Products/Complaint Analysis

    Regulatory Affairs Personnel

    Quality Engineers

    Clinical Affairs Personnel

    Complaint Handling Unit Personnel

    Compliance Specialists

    For more information, please visit : https://www.atozcompliance.com/trainings-webinar/life-sciences/medical-devices/post-market-surveillance-and-vigilance-webinar-training/susanne-manz/300201?utm_source=ref&utm_medium=23Feb

    Email: supportatatozcompliance.com

    Toll Free: +1- 844-414-1400

    Tel: +1-516-900-5509

    Level:

    Intermediate

    Speakers Profile :

    Susanne Manz

    Susanne Manz, MBA, MBB, RAC, CQA is an accomplished leader in the medical device industry with emphasis on quality, compliance, and six sigma. She has an extensive background in quality and compliance for medical devices from new product development, to operations, to post-market activities.

    Susanne has a BS in Biomedical Engineering and an MBA from the University of NM. She earned her Black Belt and Master Black Belt certifications while at Johnson and Johnson. Susanne also holds Regulatory Affairs Certification (RAC) from RAPS and Certified Quality Auditor (CQA) certification from the American Society for Quality.

    Susanne has now established a consulting business with a mission to provide services to help medical device companies achieve world-class quality and compliance.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.